leh kem' bee Speaker icon
lecanemab Speaker icon

leqembi logo
The now-approved, at-home, single-dose prefillled autoinjector of LEQEMBI® (lecanemab-irmb)

NOW APPROVED

NOW APPROVED

LEQEMBI® IQLIK™ once-weekly
at-home subcutaneous injection

After 18 months of treatment
(twice-
monthly infusion), patients
can
now
transition to LEQEMBI IQLIK.1 

Explore dosing
Two women picking fruit from a tree
Two women picking fruit from a tree

LEQEMBI® Companion™: Patient Support Program

LEQEMBI Companion logo

The LEQEMBI Companion program can help patients understand insurance coverage, identify financial support, and more. Once enrolled, they’ll be connected with a dedicated Patient Navigator who can help them know what to expect at each step with infusions and injections.

LEQEMBI Companion includes:

Support for access and cost

Eisai Patient Support

As a part of the LEQEMBI Companion program, Eisai Patient Support (EPS) can offer patients information and resources to help them access LEQEMBI. The support program can help with:

  • Understanding insurance coverage and potential out-of-pocket costs
  • Identifying financial support programs, including the LEQEMBI Copay Assistance Program for eligible patients  
  • Locating an infusion center

Resources to support patients starting
on LEQEMBI® IQLIK™

Patients prescribed LEQEMBI IQLIK can get resources to help with getting started and staying on track with their treatment schedule.

LEQEMBI Injection icon

One-on-one injection support
Patients can get comfortable injecting with the help of a Nurse Educator* who can provide injection support either in person or virtually. They cannot, however, provide medical advice. 

Briefcase icon

A welcome kit
The kit is filled with educational resources to help you build confidence with injecting and stay on schedule. 

*Nurse Educators are provided by Eisai and Biogen (manufacturers of LEQEMBI) and do not work under the direction of your health care provider.

The LEQEMBI Companion program can help patients understand insurance coverage, identify financial support, and more.
Call
1-833-4-LEQEMBI (1-833-453-7362) or click here.

LEQEMBI Companion logo

Resources for Your
Patients and Practice

Do you have patients who may benefit from virtual care? Refer them to an independent specialist. These experts can help determine what type of evaluation is right for your patients. Get started through one of the telehealth providers below:

Isaac Health Synapticure

ARIA is a consequence of amyloid presence in blood vessel walls that can occur spontaneously in patients with AD or as a result of treatment with a monoclonal antibody (including LEQEMBI) that removes amyloid.1-7

Learn more about ARIA

You can also register your practice as an infusion center for LEQEMBI.

Register here

Locate an infusion center where your patient can receive treatment with LEQEMBI.

Use the LEQEMBI Locator Tool*

*This tool is developed, hosted and maintained by the National Infusion Center Association (NICA), an organization independent from Eisai. Eisai does not control or validate the content on the NICA Infusion Center Locator website. By making this link available, Eisai is not endorsing or recommending any particular infusion provider. The list of infusion providers searchable in the Locator is not comprehensive. Other infusion providers may be available to patients. An infusion site that would like to request to be added to the NICA Infusion Center Locator may contact NICA. When using the NICA Infusion Center Locator, it is the responsibility of the referring prescriber and/or patient to contact the site directly for any site-specific questions, including to confirm whether a site offers the prescribed medication, accepts the patient’s insurance, and has schedule availability.

Physician Locator Tool Quickly find appropriate specialists who may provide additional clinical evaluations for your patients

Quickly find appropriate specialists who may provide additional clinical evaluations for your patients